- Investing Ideas
- Indian Pharmaceuticals & Biotech High ROE Growth Engines
Indian Pharmaceuticals & Biotech High ROE Growth Engines
Results
7
7 companies
Abbott India
Market Cap: ₹592.6b
Operates as a pharmaceutical company in India.
500488
₹27,885.85
7D
1.2%
1Y
-14.9%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹437.0b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,579.60
7D
-1.2%
1Y
-3.7%
Ajanta Pharma
Market Cap: ₹433.4b
A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
AJANTPHARM
₹3,470.40
7D
1.0%
1Y
32.5%
Neuland Laboratories
Market Cap: ₹275.8b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹21,499.95
7D
11.9%
1Y
67.5%
CORONA Remedies
Market Cap: ₹125.1b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹2,045.50
7D
-2.2%
1Y
n/a
Sat Kartar Life
Market Cap: ₹1.9b
An ayurvedic healthcare company, provides ayurvedic products in India.
SATKARTAR
₹119.65
7D
-8.3%
1Y
-33.5%
Colinz Laboratories
Market Cap: ₹206.4m
Manufactures, markets, and trades in pharmaceutical formulations in India.
531210
₹81.95
7D
2.4%
1Y
85.6%